Randomized, open-label trial of gemcitabine/nab-paclitaxel (G/NP) ±FG-3019 as neoadjuvant chemotherapy in locally advanced, unresectable pancreatic cancer (LAPC).

被引：2
|
作者：
Picozzi, Vincent J.
Rocha, Flavio G.
Helton, Scott
Mody, Kabir
Asbun, Horacio
Pishvaian, Michael J.
Jackson, Patrick G.
Etheridge, Tina
Carney, Mairead
Neff, Thomas B.
Porter, Seth
Crans, Gerald
Valone, Frank
Shi, Wen
机构：
[1] Virginia Mason Med Ctr, Seattle, WA 98101 USA
[2] Mayo Clin, Jacksonville, FL 32224 USA
[3] Georgetown Univ, Lombardi Comprehens Canc Ctr, Washington, DC USA
[4] FibroGen Inc, San Francisco, CA USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2016年 / 34卷 / 04期
关键词：
D O I：
10.1200/jco.2016.34.4_suppl.457
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
457
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Conversion surgery with gemcitabine plus nab-paclitaxel for locally advanced unresectable pancreatic cancer: A case report
    Okura, Ryosuke
    Takano, Shigetsugu
    Yokota, Tetsuo
    Yoshitomi, Hideyuki
    Kagawa, Shingo
    Furukawa, Katsunori
    Takayashiki, Tsukasa
    Kuboki, Satoshi
    Suzuki, Daisuke
    Sakai, Nozomu
    Nojima, Hiroyuki
    Mishima, Takashi
    Miyazaki, Masaru
    Ohtsuka, Masayuki
    MOLECULAR AND CLINICAL ONCOLOGY, 2018, 9 (04) : 389 - 393
  • [22] Neoadjuvant Nab-paclitaxel and Gemcitabine in Borderline Resectable or Locally Advanced Unresectable Pancreatic Adenocarcinoma in Patients Who Are Ineligible for FOLFIRINOX
    Peterson, Shawn L.
    Husnain, Muhammad
    Pollack, Terri
    Pimentel, Agustin
    Loaiza-Bonilla, Arturo
    Westendorf-Overley, Colleen
    Ratermann, Kelley
    Anthony, Lowell
    Desimone, Philip
    Goel, Gaurav
    Kudrimoti, Mahesh
    Dineen, Sean
    Tzeng, Ching-Wei D.
    Hosein, Peter J.
    ANTICANCER RESEARCH, 2018, 38 (07) : 4035 - 4039
  • [23] International phase II trial of weekly nab-paclitaxel (nab-P) plus gemcitabine (Gem) in patients with locally advanced pancreatic cancer (LAPC): LAPACT
    Philip, P.
    Kayitalire, L.
    Nydam, T.
    Penenberg, D.
    Hammel, P.
    ANNALS OF ONCOLOGY, 2015, 26
  • [24] Effects and Problems of Neoadjuvant Chemotherapy Using Gemcitabine plus Nab-Paclitaxel for Advanced Pancreatic
    Tomita, K.
    Chiba, N.
    Nakagawa, M.
    Koganezawa, I.
    Yokozuka, K.
    Ozawa, Y.
    Kobayashi, T.
    Sano, T.
    Tsutsui, R.
    Kawachi, S.
    PANCREAS, 2019, 48 (10) : 1537 - 1537
  • [25] FOLFIRINOX and Gemcitabine/nab-Paclitaxel Demonstrate Improved Survival in Locally Advanced Unresectable Pancreatic Adenocarcinoma
    Bednar, F.
    Ocuin, L.
    Steve, J.
    Zenati, M.
    Winters, S.
    Hogg, M.
    Bahary, N.
    Zeh, H., III
    Zureikat, A.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 : S175 - S176
  • [26] Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
    Tsujimoto, Akiko
    Sudo, Kentaro
    Nakamura, Kazuyoshi
    Kita, Emiri
    Hara, Ryusuke
    Takayama, Wataru
    Ishii, Hiroshi
    Yamaguchi, Taketo
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [27] FOLFIRINOX and gemcitabine/nab-paclitaxel efficacy in the treatment of locally advanced unresectable pancreatic adenocarcinoma.
    Bednar, Filip
    Ocuin, Lee Mayer
    Steve, Jennifer
    Zenati, Mazen S.
    Winters, Sharon
    Hogg, Melissa Ellen
    Bahary, Nathan
    Zeh, Herbert J.
    Zureikat, Amer H.
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [28] Gemcitabine plus nab-paclitaxel for locally advanced or borderline resectable pancreatic cancer
    Akiko Tsujimoto
    Kentaro Sudo
    Kazuyoshi Nakamura
    Emiri Kita
    Ryusuke Hara
    Wataru Takayama
    Hiroshi Ishii
    Taketo Yamaguchi
    Scientific Reports, 9
  • [29] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
    Suguru Yamada
    Tsutomu Fujii
    Yukihiro Yokoyama
    Hiroki Kawashima
    Osamu Maeda
    Kojiro Suzuki
    Tohru Okada
    Eizaburo Ono
    Junpei Yamaguchi
    Nao Takano
    Hideki Takami
    Masamichi Hayashi
    Yukiko Niwa
    Yoshiki Hirooka
    Yoshiyuki Ito
    Shinji Naganawa
    Yuichi Ando
    Masato Nagino
    Hidemi Goto
    Yasuhiro Kodera
    Cancer Chemotherapy and Pharmacology, 2018, 81 : 815 - 821
  • [30] Phase I study of chemoradiotherapy using gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic cancer
    Yamada, Suguru
    Fujii, Tsutomu
    Yokoyama, Yukihiro
    Kawashima, Hiroki
    Maeda, Osamu
    Suzuki, Kojiro
    Okada, Tohru
    Ono, Eizaburo
    Yamaguchi, Junpei
    Takano, Nao
    Takami, Hideki
    Hayashi, Masamichi
    Niwa, Yukiko
    Hirooka, Yoshiki
    Ito, Yoshiyuki
    Naganawa, Shinji
    Ando, Yuichi
    Nagino, Masato
    Goto, Hidemi
    Kodera, Yasuhiro
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (05) : 815 - 821
12345